Updated : 2 weeks, 3 days ago IST
New Delhi [India], June 14 (ANI): Union Health Ministry on Sunday said that drug Remdesivir has been included as an "investigational therapy" only for restricted emergency use on COVID-19 patients.
Updated : 2 weeks, 4 days ago IST
Hyderabad (Telangana) [India], June 13 (ANI): Dr Reddy's Laboratories said on Saturday it has entered into a non-exclusive licensing agreement with Gilead Sciences Inc that will grant Dr Reddy's the right to register, manufacture and sell Gilead's investigational drug Remdesivir, a potent
Updated : 1 month ago IST
Bengaluru (Karnataka) [India] May 28 (ANI/PRNewswire): All India Institute of Medical Sciences (AIIMS), Rishikesh has teamed up with Stasis, a Bengaluru-based start-up, to implement a remote patient monitoring solution to manage COVID-19 suspects/patients in isolation wards.
Updated : 7 months, 1 week ago IST
Mumbai (Maharashtra) [India], Nov 27 (ANI/NewsVoir): Centaur Pharmaceuticals' state-of-the-art API Ambernath facility was audited by the USFDA and a 483 form was issued with one observation which was responded to, immediately.
Updated : 9 months ago IST
New Delhi [India], Oct 5 (ANI): The growth and profitability of Indian pharmaceutical companies in current financial year will be constrained by regulatory interventions like price controls in domestic market and compulsory genericisation in overseas market, according to ICRA Ratings.
Updated : 10 months, 1 week ago IST
Bengaluru (Karnataka) [India], Aug 27 (ANI): Strides Pharma Science Ltd said on Tuesday that its step-down subsidiary Strides Pharma Inc has acquired a manufacturing facility in Florida from Micelle BioPharma Inc.
Updated : 10 months, 3 weeks ago IST
New Delhi [India] August 14 (ANI/NewsVoir): Morepen Laboratories Ltd has reported a 256 per cent rise in its net profit (standalone) at Rs 8.41 crore in the first quarter (Q1) of FY 2019-20 as against Rs 2.36 crore net profit registered in the corresponding quarter of the previous fiscal.
Updated : 11 months, 3 weeks ago IST
Mumbai (Maharashtra) [India], July 15 (ANI): Pharma company Indoco Remedies said on Monday it has received a warning letter from the United States Food and Drug Administration (USFDA) for its oral dosages plant in Goa as a result of the inspection carried out in January.
Updated : 1 year ago IST
Pune (Maharashtra) [India] June 11 (ANI/BusinessWire India): Mumbai based Centaur Pharmaceuticals' finished dosage facility in Pune was audited by the USFDA in May 2019 and the audit was concluded with NIL 483 observations.
Updated : 1 year, 3 months ago IST
Noida (Uttar Pradesh) [India], Mar 8 (ANI): Jubilant Life Sciences said on Friday that the US Food and Drug Administration (USFDA) has issued a warning letter after conducting an inspection at its manufacturing facility in Roorkee, Uttarakhand.
Updated : 1 year, 4 months ago IST
New Delhi [India], Feb 26 (ANI): Aavis Pharmaceuticals, part of Espee Group, located in Hoschton, GA, completed an inspection by the US Food and Drug Administration at the company’s primary manufacturing facility with Zero 483 observations. With successful inspection of its formulat
Updated : 1 year, 11 months ago IST
New Delhi [India], July 30 (NewsVoir): Morepen Laboratories Ltd. has received US FDA (United States Food and Drug Administration) approvals for both its bulk drugs manufacturing facilities situated in Himachal Pradesh.